hepatitis_c_drug-fda.jpeg - Washington Times
Skip to content

Gilead Sciences, producer of the hepatitis C cure called Epclusa, has struck a deal with Louisiana in an experiment that health care policy analysts say could serve as a national model for managing rising drug prices. (Associated Press/File)

Gilead Sciences, producer of the hepatitis C cure called Epclusa, has struck a deal with Louisiana in an experiment that health care policy analysts say could serve as a national model for managing rising drug prices. (Associated Press/File)

Featured Photo Galleries